期刊文献+

厄贝沙坦氢氯噻嗪分散片对老年原发性高血压治疗效果评价 被引量:2

Evaluation of the Curative Effect of Irbesartan and Hydrochlorothiazide Dispersible Tablets in the Treatment of Senile Primary Hypertension
下载PDF
导出
摘要 目的探讨厄贝沙坦氢氯噻嗪分散片对老年原发性高血压治疗效果。方法选取2013年7月~2015年7月到我院就诊的80例老年原发性高血压患者,按随机分组法,将80例患者分为观察组(n=40例)和对照组(n=40例),对照组采用厄贝沙坦片治疗,观察组采用厄贝沙坦氢氯噻嗪分散片治疗。比较两组患者治疗前后血压的变化及治疗效果。结果治疗后,两组患者的收缩压、舒张压均下降,且观察组患者的收缩压、舒张压下降幅度高于对照组,差异均有统计学意义(P<0.05)。观察组患者治疗总有效率高于对照组,差异有统计学意义(P<0.05。结论应用厄贝沙坦氢氯噻嗪分散片治疗老年原发性高血压效果显著。 Objective To investigate the therapeutic effect of Irbesartan and hydrochlorothiazide dispersible tablets in the treatment of senile primary hypertension. Methods From July 2013 to July 2015, 80 casesof elderly hypertensive patients in our hospital were randomly divided into observation group (n=40) and control group (n=40), control group was treated with irbesartan tablets, and the observation group was treated with irbesartan and hydrochlorothiazide dispersible tablets, to compare the change of blood pressure and the therapeutic effect of two groups. Results After treatment, systolic blood pressure and diastolic blood pressure decreased in both two groups, but the decrease amplitude of the observation group was higher than that of control group, the total efficiency of observation group was higher than that of control group, the difference was statistically significant (P〈0.05). Conelusion The therapeutic effect of irbesartan and hydrochlorothiazide dispersible tablets in the treatment of elderly 6atients with orimarv primary hvoertension has significant effects.
作者 商杰
出处 《中国继续医学教育》 2016年第11期193-195,共3页 China Continuing Medical Education
关键词 厄贝沙坦 氢氯噻嗪 老年 原发性高血压 Irbesartan, Hydrochlorothiazide, Elderly, Hypertension
  • 相关文献

参考文献3

二级参考文献12

  • 1吴本俨.老年人消化系统的衰老改变[J].中华老年医学杂志,2007,26(1):76-78. 被引量:28
  • 2Papp R,Csaszar A,Paulik E,et al. Correlations between prescription of anti - hypertensive medication and mortality due to stroke [ J ]. BMC Cardiovasc Disord,2012 ; 12 : 15 - 17.
  • 3Fan HQ, Li Y, Thijs L, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations[ J]. Hypertension, 2010;55 : 1040 - 1048.
  • 4Chhabra G,Chuttani K,Mishra AK,et al. Design and development of nanoemulsion drug delivery- system of amlodipine besilate for improvement of oral bioavailability[ J]. Drug Dev Ind Pharm,2011 ;37:907 -916.
  • 5Greathouse MK, Weir MR. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and re- nal complications[ J]. Postgrad Med, 2012 ; 124:40 - 52.
  • 6Sonoda M, Aoyagi T, Takenaka K, et al. A one - year study of the antiatherosclerotic effect of the angiotensin - II receptor blocker losar- tan in hypertensive patients. A comparison with angiotension - con- vetting enzyme inhibitors[ J]. Int Heart J, 2008 ; 49:95 - 103.
  • 7Coyle D, Rodby R, Soroka S, et al. Cost - effectiveness of irbrsartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabeetes and renal disease: a Canadian perspective [J]. Clin Ther, 2007; 29:1508-1523.
  • 8无.β肾上腺素能受体阻滞剂在心血管疾病应用专家共识[J].中华心血管病杂志,2009,37(3):195-209. 被引量:202
  • 9张中明.施慧达联合双氢克尿噻治疗老年收缩期高血压临床观察[J].中国社区医师(医学专业),2009,11(12):24-24. 被引量:2
  • 10李玲玲,李晶.施慧达与络活喜对原发性高血压疗效的比较[J].中国实用医药,2010,5(16):173-174. 被引量:4

共引文献125

同被引文献19

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部